RFI JPEO CBRND Joint Project Manager CBRN Medical
ID: W911SR-JPEO-CBRND-JPM-MedicalType: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW6QK ACC-APGABERDEEN PROVING GROU, MD, 21010-5424, USA

Original Source

https://sam.gov/opp/2d8a78a1c37d443eb017c1ea9302317a/view
Timeline
    Description

    The Department of Defense, through the Joint Project Manager CBRN Medical within the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), is seeking capabilities that enhance Chemical, Biological, Radiological, and Nuclear Defense (CBRND). The focus is on innovative medical solutions, including medical countermeasures such as vaccines, diagnostics, and therapeutics, which are vital for protecting service members against CBRN threats. Interested parties with technologies in areas such as chemical prophylaxis, new vaccine platforms, host-directed therapeutics, and AI predictive mechanisms are encouraged to engage with the project team. For further information and to schedule a meeting, contact Allison Pizzo at allison.m.pizzo.civ@army.mil or call 520-671-1593, and visit the JETT registration page at https://jacks.jpeocbrnd.army.mil/JETT.

    Point(s) of Contact
    Allison Pizzo
    (520) 671-1593
    allison.m.pizzo.civ@army.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    RFI JPEO CBRND Joint Project Manager CBRN Medical
    Currently viewing
    Special Notice
    Similar Opportunities
    JPEO-CBRND RFI - Wearable CBRN Threat Monitoring Sensors
    Dept Of Defense
    The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is seeking information on wearable CBRN threat monitoring sensors as part of a Request for Information (RFI). The objective is to gather insights on technologies capable of real-time monitoring of various physiological and environmental parameters, including vital signs, cognitive performance, and exposure to chemical, biological, radiological, and nuclear threats, while maintaining low size, weight, and power attributes. These sensors are crucial for enhancing operational safety and effectiveness in environments where CBRN threats may be present. Interested parties are encouraged to submit white papers and technical briefs detailing their capabilities, with responses to be submitted via the Joint Enterprise Technology Tool (JETT) platform. This RFI is for information and planning purposes only, and no funding amount or contract award timeline has been specified.
    JPEO-CBRND CWMD BOTAA-24-01
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEPT OF THE ARMY: The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking funding through Other Transaction Authority agreements (OTAs) for prototype and follow-on production projects within JPEO-CBRND mission areas of interest. The service being procured is the development of enabling technologies that speed up the advanced development process. This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry. Proposals are to be submitted in accordance with the provided guidelines. For more information, please refer to the JPEO-CBRND website.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    JPEO-CBRND RFI - Genomic Sequencing Workflows
    Dept Of Defense
    The Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is issuing a Request for Information (RFI) to gather insights on end-to-end untargeted genomic sequencing workflows suitable for military applications. The RFI seeks to identify industry capabilities in developing genomic sequencing workflows, field-deployable bioinformatics tools, test and evaluation infrastructure, and protein toxin sequencing capabilities, all tailored for military users with varying technical expertise. This initiative is crucial for enhancing military readiness and response to biological threats through advanced genomic technologies. Interested parties are invited to submit their responses by January 9, 2026, with an Industry Day scheduled for January 29, 2026, at the SPA, Crown Center Conference Facility in Lorton, VA. For more information and to respond, please visit the Joint Enterprise Technology Tool (JETT) page.
    Chemical Biological Mask Equipment Tester (CBMET) Modernization Effort
    Dept Of Defense
    The Department of Defense, specifically the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is soliciting pre-proposals for the modernization of the Chemical Biological Mask Equipment Tester (CBMET) portfolio. The objective is to develop a consolidated testing solution that assesses mask fit and serviceability for current and future CBRN protective masks, addressing issues of obsolescence and material shortages. This initiative is critical for enhancing military personnel's mission effectiveness and defense capabilities against Weapons of Mass Destruction (WMD). Interested parties must submit their pre-proposals electronically to the designated contacts by 5:00 PM EST on December 22, 2025, with further inquiries directed to the provided email addresses.
    DRAFT: OB BP IDIQ
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is seeking qualified contractors for the DRAFT: OB BP IDIQ opportunity, aimed at enhancing the capacity of partner nations to counter weapons of mass destruction (WMD) and chemical, biological, radiological, and nuclear (CBRN) threats. The contract will primarily support DTRA's Countering-WMD Security Cooperation Engagement Program (CSCEP) and the International Counterproliferation Program (ICP), focusing on establishing or enhancing partner nation capabilities to deter, detect, interdict, or respond to WMD proliferation. This initiative is critical for the Department of Defense and U.S. Government in their efforts to deter strategic attacks and prevail against WMD-armed adversaries. Interested parties can reach out to primary contact Jocelyn Fritz at jocelyn.m.fritz.civ@mail.mil or 571-616-5277, or secondary contact Eric Rode at eric.m.rode.civ@mail.mil or 571-616-6145 for further information. The final Request for Proposal (RFP) is expected to be issued before the end of the fiscal year, with updates available on the SAM.gov entry.
    DTRA CWMD Security Cooperation Engagement Program IDIQ
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is seeking contractors for the Countering Weapons of Mass Destruction (CWMD) Security Cooperation Engagement Program (CSCEP) through an Indefinite Delivery Indefinite Quantity (IDIQ) contract. This program aims to enhance the capabilities of partner nations in responding to Chemical, Biological, Radiological, and Nuclear (CBRN) incidents, thereby improving global national security. The contractor will be responsible for training, equipping, and supporting partner nations, including logistics management and event planning, with a focus on compliance with U.S. and international regulations. Interested parties should note that the solicitation will be released in the second quarter of fiscal year 2025, and inquiries can be directed to Jocelyn Fritz or Eric M Rode at the provided email address.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), has issued a Broad Agency Announcement (BAA) to solicit proposals for innovative research and development in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. This solicitation is open continuously for up to five years and invites proposals from educational institutions, nonprofit organizations, and private industry, focusing on areas such as detection technologies, modeling and simulation, and countermeasures to terrorism. The BAA is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' dominance on the battlefield and homeland defense. Interested parties can contact Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil or Lionel Love at lionel.d.love.civ@army.mil for further information regarding proposal submissions and evaluation criteria.
    BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is conducting market research for the development of a barrier combination product aimed at preventing and treating battlefield wounds and subsequent infections. This initiative, part of the Battlefield Wound Infection Prevention and Treatment (BWI P&T) program, seeks to identify commercial solutions that can effectively address the unique challenges of wound care in austere environments, where medical resources may be limited. The barrier combination product is expected to play a crucial role in a Family of Systems (FoS) approach, providing innovative solutions for both military and commercial applications in wound care. Interested parties are invited to submit their responses by January 20, 2026, at 2:00 PM Eastern, via email to the primary contacts, Jeanette Collins and Julie Burns, whose emails are provided in the opportunity overview. This RFI is for planning purposes only, and no contract will be awarded based on the responses received.
    J&A Procurement of Smallpox (Mpox) Vaccine for the Strategic National Stockpile
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking to procure additional doses of the JYNNEOS™ vaccine for the Strategic National Stockpile in response to the ongoing monkeypox outbreak. The procurement aims to rapidly secure 11 million doses of the vaccine by utilizing existing bulk drug substance and to enhance manufacturing capacity through technology transfer to contract manufacturing organizations. The JYNNEOS™ vaccine is critical as it is the only licensed vaccine for both smallpox and monkeypox, making it essential for public health preparedness. Interested parties can contact Yifan Yang at yifan.yang@hhs.gov, with the total estimated value of the contract modification being $992,400,000.